Telomere Dysfunction Results in Enhanced Organismal Sensitivity to the Alkylating Agent N-Methyl-N-Nitrosourea

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7047-7050

  González Suárez, Eva ^a   Goytisolo, Fermín A ^a   Flores, Juana M ^b   Blasco, María A ^a,c  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARCINOGEN; METHYLNITROSOUREA;

ACUTE TOXICITY; ARTICLE; CANCER INHIBITION; CARCINOMA; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE; TUMOR GROWTH;

ALKYLATING AGENTS; ANIMALS; FEMALE; MALE; METHYLNITROSOUREA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; TELOMERASE; TELOMERE;

EID: 0242694970     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Blackbum, E. H. Structure and function of telomeres. Nature (Lond.), 350: 569-573, 1991.
2. Nugent, C. I., and Lundblad, V. The telomerase reverse transcriptase: components and regulation. Genes Dev., 12: 1073-1085, 1998.
3. Goytisolo, F. A., and Blasco, M. A. Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene, 21: 584-591, 2002.
4. Blasco, M. A., Lee, H. W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., and Greider, C. W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91: 25-34, 1997.
5. Wong, K. K., Chang, S., Weiler, S. R., Ganesan, S., Chaudhuri, J., Zhu, C., Artandi, S. E., Rudolph, K. L., Gottlieb, G. J., Chin, L., Alt, F. W., and DePinho, R. A. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat. Genet., 26: 85-88, 2000.
6. Goytisolo, F. A., Samper, E., Martin-Caballero, J., Finnon, P., Herrera, E., Flores, J. M., Bouffler, S. D., and Blasco, M. A. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J. Exp. Med., 192: 1625-1636, 2000.
7. Lee, K. H., Rudolph, K. L., Ju, Y. J., Greenberg, R. A., Cannizzaro, L., Chin, L., Weiler, S. R., and DePinho, R. A. Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Natl. Acad. Sci. USA, 98: 3381-3386, 2001.
8. González-Suárez, E., Samper, E., Flores, J. M., and Blasco, M. A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet., 26: 114-117, 2000.
9. 6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res., 60: 5815-5824, 2000.
10. Bernstein, C., Bernstein, H., Payne, C. M., and Garewal, H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res., 511: 145-178, 2002.
11. Dement'eva, N. P., and Korman, D. B. Nitrosomethylurea: 30 years of study and use in the treatment of cancer patients (in Russian). Vopr. Onkol., 47: 655-661, 2001.
12. Herrera, E., Samper, E., Martin-Caballero, J., Flores, J. M., Lee, H. W., and Blasco, M. A. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J., 18: 2950-2960, 1999.
13. Grant, W. F., and Salamone, M. F. Comparative mutagenicity of chemicals selected for test in the International Program on Chemical Safety's collaborative study on plant systems for the detection of environmental mutagens. Mutat. Res., 310: 187-209, 1994.
14. Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H., Meyerson, M., and Weinberg, R. A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med., 5: 1164-1170, 1999.
15. Lee, H. W., Blasco, M. A., Gottlieb, G. J., Homer, J. W., II, Greider, C. W., and DePinho, R. A. Essential role of mouse telomerase in highly proliferative organs. Nature (Lond.), 392: 569-574, 1998.
16. Masutomi, K., and Hahn, W. C. Telomerase and tumorigenesis. Cancer Lett., 194: 163-172, 2003.
17. Blasco, M. A. Telomerase beyond telomeres. Nat. Rev. Cancer, 2: 627-633, 2002.
18. Mattson, M. P., and Klapper, W. Emerging roles for telomerase in neuronal development and apoptosis. J. Neurosci. Res., 63: 1-9, 2001.
19. Gonzalez-Suarez, E., Samper, E., Ramirez, A., Flores, J. M., Martin-Caballero, J., Jorcano, J. L., and Blasco, M. A. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J., 20, 2619-2630, 2001.
20. Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Homer, J. W., Weiler, S. R., Carrasco, R. D., and DePinho, R. A. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl. Acad. Sci. USA, 99: 8191-8196, 2002.
21. Latre, L., Tussell, L., Martin, M., Miro, R., Egozcue, J., Blasco, M. A., and Genesca, A. Shortened telomeres join DNA breaks interfering with their correct repair. Exp. Cell Res., 287: 282-288, 2003.
22. Cherif, H., Tarry, J. L., Ozanne, S. E., and Hales, C. N. Aging and telomeres: a study into organ- and gender-specific telomere shortening. Nucleic Acids Res., 31: 1576-1583, 2003.
23. Li, J. L., Okada, S., Hamazaki, S., Ebina, Y., and Midorikawa, O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res., 47: 1867-1869, 1987.